Interdisciplinary Science Research Institute, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, China.
Biomed Chromatogr. 2022 Jan;36(1):e5235. doi: 10.1002/bmc.5235. Epub 2021 Oct 14.
Dingkun Dan (DKD), a reputable traditional Chinese medicine formula, has been used to treat gynecological diseases and showed significant clinical effects since ancient times. However, the application and development of DKD are seriously hampered by the unclear active substances. Structural characterization of compounds absorbed in vivo and their corresponding metabolites is significant for clarifying the pharmacodynamic material basis. In this study, an integrated strategy using ultra-performance liquid chromatography, coupled with quadrupole time-of-flight mass spectrometry and UNIFI™ software, was used to identify prototypes and metabolites after oral administration of DKD in rats. As a result, a total of 261 compounds, including 140 prototypes and 121 metabolites, were tentatively characterized in rat plasma, urine, and feces. The metabolic pathways of prototypes have been studied to clarify their possible transformation process in vivo. Moreover, an in vitro metabolism study was applied for verifying the metabolites under simulating the metabolic environment in vivo. This first systematic metabolic study of DKD is important for elucidating the metabolites and metabolic pathways and could provide a scientific basis for explaining the integrative mechanism in further pharmacology study.
丹(DKD),一种著名的中药方剂,自古以来就被用于治疗妇科疾病,并显示出显著的临床效果。然而,DKD 的应用和发展受到其活性物质不明确的严重阻碍。对体内吸收的化合物及其相应代谢物的结构进行表征,对于阐明药效物质基础具有重要意义。在这项研究中,采用超高效液相色谱-四级杆飞行时间质谱联用技术和 UNIFI 软件,建立了一种综合策略,用于鉴定大鼠口服 DKD 后的原型药物和代谢产物。结果,共鉴定出 261 种化合物,包括 140 种原型药物和 121 种代谢产物,分别在大鼠血浆、尿液和粪便中进行了鉴定。对原型药物的代谢途径进行了研究,以阐明其在体内的可能转化过程。此外,还进行了体外代谢研究,以验证体内模拟代谢环境下的代谢物。这是首次对 DKD 的系统代谢研究,对于阐明其代谢物和代谢途径具有重要意义,并可为进一步的药理学研究提供解释其整体作用机制的科学依据。